Company Data

Virios Therapeutics Inc.

Ticker
VIRI
Price Target
Refer to Report
Volume
47.7K
52wk Range
$3.15 - $26
Advanced Market Data

Overview

Virios Therapeutics Inc is a development-stage biotechnology company. It is focused on advancing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response such as fibromyalgia. The company is engaged in the development of its product, IMC-1, for people who are suffering from fibromyalgia.

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy